Related Experiment Video

Updated: Feb 24, 2026

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
06:33

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

2.7K

Translating the Potential of Stem Cells for Diabetes Mellitus: Challenges and Opportunities

Muhammad Shareef Masoud1, Muhammad Qasim1, Muhammad Umar Ali1

  • 1Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Allama Iqbal Road, 38000, Pakistan.

Current Stem Cell Research & Therapy
|August 24, 2017
PubMed
Abstract

Insights

Stem cells offer a promising approach for regenerating pancreatic beta cells to treat diabetes mellitus. While challenges remain, regenerative medicine using stem cells shows potential for future clinical applications and improved diabetes management.

Area of Science:

  • Endocrinology
  • Regenerative Medicine
  • Cell Biology

Background:

  • Diabetes mellitus is a prevalent metabolic disorder characterized by pancreatic beta cell dysfunction or loss.
  • Cell therapy, particularly using stem cells, presents a potential strategy for beta cell regeneration and restoring metabolic control.
  • Research is exploring stem cells, cellular reprogramming, and beta cell regeneration for diabetes treatment.

Purpose of the Study:

  • To review and summarize existing literature on stem cell applications for pancreatic beta cell regeneration.
  • To assess the potential of stem cells in treating diabetes mellitus.

Main Methods:

  • Literature review of studies investigating stem cell therapy for diabetes.
  • Analysis of research on stem cell self-renewal and differentiation capabilities relevant to beta cell regeneration.

Main Results:

  • Stem cells possess inherent properties of self-renewal and multipotency, crucial for regenerative approaches.
  • The potential for stem cells to regenerate pancreatic beta cells and treat diabetes is significant.
  • Several milestones must be achieved before widespread clinical application.

Conclusions:

  • Stem cell-based regenerative medicine holds considerable promise for treating diabetes mellitus.
  • Future research may lead to novel methodologies for diabetes cure and mitigation.
  • Widespread clinical use of stem cells and regenerative medicine for diabetes is anticipated.
Keywords:
Diabetes mellitusadult stem cellsembryonic stem cells (ESCs)induced pluripotent stem cells (IPSCs)mesenchymal stem cells (MSCs)pancreatic stem cells

More Related Videos

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

3.8K
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

3.3K

Related Concept Videos

Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K